• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素(1-34)和(1-84)可刺激骨膜和骨内膜的皮质骨形成。

Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.

作者信息

Oxlund H, Ejersted C, Andreassen T T, Tørring O, Nilsson M H

机构信息

Department of Connective Tissue Biology, University of Aarhus, Denmark.

出版信息

Calcif Tissue Int. 1993 Dec;53(6):394-9.

PMID:8293353
Abstract

The anabolic effect of intermittent treatment with parathyroid hormone (PTH) on cortical bone was investigated. Groups of rats were injected with human PTH (1-34) or PTH (1-84), 1.1, 3.3, 10, and 30 nmol/kg/day for 30 days. A dose-related increase in bone formation rate at the femoral middiaphysis was found at both the periosteum and the endosteum and also an increase in bone mass, with no change in the bone lengths or body weight gain of the rats. The highest mineral apposition rate, as analyzed by tetracycline labeling, was found at the periosteal postero-medial aspect and at the endosteal anterior aspect. This pattern of bone modeling was also found in the PTH-treated animals, although more and more areas were included in bone mineral apposition. The PTH treatments did not change the porosity of the cortical bone nor the concentration and biochemical stability of the collagen. The highest doses of PTH resulted in a slight reduction in the ash concentration of cortical bone. No differences were found between the effects of PTH (1-34) and PTH (1-84) on bone formation rate, bone mass, porosity, and biochemical parameters. Consequently, intermittent treatment with PTH increased the formation of cortical bone dose dependently, at both the periosteum and the endosteum and increased the bone mass of these growing rats, with no change in the body weight gain or femoral growth rate compared with the control animals. The responses of the cortical bone modeling were increased by the PTH treatments without changing its direction or pattern.

摘要

研究了甲状旁腺激素(PTH)间歇治疗对皮质骨的合成代谢作用。将大鼠分组,分别注射人PTH(1-34)或PTH(1-84),剂量为1.1、3.3、10和30 nmol/kg/天,持续30天。在股骨中骨干的骨膜和内膜处均发现骨形成率呈剂量相关增加,骨量也增加,而大鼠的骨长度或体重增加无变化。通过四环素标记分析发现,最高的矿物质沉积率出现在骨膜后内侧和内膜前侧。在PTH治疗的动物中也发现了这种骨重塑模式,尽管骨矿物质沉积的区域越来越多。PTH治疗并未改变皮质骨的孔隙率,也未改变胶原蛋白的浓度和生化稳定性。最高剂量的PTH导致皮质骨灰分浓度略有降低。PTH(1-34)和PTH(1-84)对骨形成率、骨量、孔隙率和生化参数的影响未发现差异。因此,与对照动物相比,PTH间歇治疗可使皮质骨在骨膜和内膜处的形成呈剂量依赖性增加,并增加这些生长中大鼠的骨量,而体重增加或股骨生长速率无变化。PTH治疗增加了皮质骨重塑的反应,但未改变其方向或模式。

相似文献

1
Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.甲状旁腺激素(1-34)和(1-84)可刺激骨膜和骨内膜的皮质骨形成。
Calcif Tissue Int. 1993 Dec;53(6):394-9.
2
Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.人甲状旁腺激素(1-34)和(1-84)可增加大鼠皮质骨的机械强度和厚度。
J Bone Miner Res. 1993 Sep;8(9):1097-101. doi: 10.1002/jbmr.5650080910.
3
Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.人合成甲状旁腺激素片段(1-34)LY333334对兔皮质骨重塑及力学性能的合成代谢作用。
J Bone Miner Res. 1999 Apr;14(4):536-45. doi: 10.1359/jbmr.1999.14.4.536.
4
Parathyroid hormone (1-34) increased total body bone mass in aged female rats.甲状旁腺激素(1-34)增加了老年雌性大鼠的全身骨量。
J Pharmacol Exp Ther. 1998 Jul;286(1):341-4.
5
Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.人甲状旁腺激素-(1-34)可预防性成熟去卵巢大鼠的骨质流失并增强骨形成。
J Bone Miner Res. 1990 Sep;5(9):973-82. doi: 10.1002/jbmr.5650050911.
6
Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.人甲状旁腺激素(1-34)循环给药与每日给药对小鼠骨骼结构和细胞活性的影响。
Bone. 2007 Feb;40(2):391-8. doi: 10.1016/j.bone.2006.09.010. Epub 2006 Oct 20.
7
Growth hormone stimulates bone formation and strength of cortical bone in aged rats.生长激素可刺激老年大鼠的骨形成及皮质骨强度。
J Bone Miner Res. 1995 Jul;10(7):1057-67. doi: 10.1002/jbmr.5650100710.
8
Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats.间歇性甲状旁腺激素对后肢去负荷大鼠松质骨的剂量反应效应。
J Bone Miner Res. 2007 Jan;22(1):64-71. doi: 10.1359/jbmr.061006.
9
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.甲状旁腺激素(PTH)对骨骼的合成代谢作用会因同时进行糖皮质激素治疗而减弱。
Bone. 2006 Aug;39(2):244-52. doi: 10.1016/j.bone.2006.01.142. Epub 2006 Feb 28.
10
Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.甲状旁腺激素可提高大鼠骨骼中胰岛素样生长因子-I和转化生长因子β1的浓度。
J Clin Invest. 1995 Aug;96(2):767-74. doi: 10.1172/JCI118121.

引用本文的文献

1
A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation.特立帕肽用于加速转子间骨折内固定患者骨愈合及改善临床结局的随机对照试验
Sci Rep. 2025 Jun 3;15(1):19465. doi: 10.1038/s41598-025-03720-2.
2
The Role of the Periosteum in Bone Formation From Adolescence to Old Age.骨膜在从青春期到老年期骨形成中的作用。
Cureus. 2025 Jan 1;17(1):e76774. doi: 10.7759/cureus.76774. eCollection 2025 Jan.
3
Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1-84).
在接受重组人甲状旁腺激素(1-84)治疗的甲状旁腺功能减退患者的皮质内骨重塑过程中,短暂激活并改善了从骨吸收到骨形成的转变。
JBMR Plus. 2023 Nov 17;7(12):e10829. doi: 10.1002/jbm4.10829. eCollection 2023 Dec.
4
Efficacy and Safety of Teriparatide in Improving Fracture Healing and Callus Formation: A Systematic Review.特立帕肽在促进骨折愈合和骨痂形成方面的疗效与安全性:一项系统评价
Cureus. 2023 Apr 12;15(4):e37478. doi: 10.7759/cureus.37478. eCollection 2023 Apr.
5
The efficacy of teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain in post-menopausal osteoporotic patients: A systematic review and meta-analysis.特立帕肽对绝经后骨质疏松症患者腰椎骨密度、椎体骨折发生率及疼痛的疗效:一项系统评价与Meta分析
Bone Rep. 2020 Oct 16;13:100728. doi: 10.1016/j.bonr.2020.100728. eCollection 2020 Dec.
6
Systemic Parathyroid Hormone Enhances Fracture Healing in Multiple Murine Models of Type 2 Diabetes Mellitus.全身性甲状旁腺激素可增强2型糖尿病多种小鼠模型的骨折愈合。
JBMR Plus. 2020 Apr 2;4(5):e10359. doi: 10.1002/jbm4.10359. eCollection 2020 May.
7
Teriparatide for treating delayed union and nonunion: A systematic review.特立帕肽治疗骨折延迟愈合和骨不连:一项系统评价。
J Clin Orthop Trauma. 2020 Feb;11(Suppl 1):S107-S112. doi: 10.1016/j.jcot.2019.10.009. Epub 2019 Nov 5.
8
Mechanical basis of bone strength: influence of bone material, bone structure and muscle action.骨强度的力学基础:骨材料、骨结构及肌肉作用的影响
J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):114-139.
9
A multiscale 3D finite element analysis of fluid/solute transport in mechanically loaded bone.机械加载骨中流体/溶质传输的多尺度三维有限元分析
Bone Res. 2016 Sep 27;4:16032. doi: 10.1038/boneres.2016.32. eCollection 2016.
10
Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis.地诺单抗对绝经后骨质疏松症女性骨密度、骨量和骨强度的影响。
Ther Adv Musculoskelet Dis. 2015 Jun;7(3):88-102. doi: 10.1177/1759720X15579189.